Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

University of Minnesota Masonic Cancer Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Employees: -

Market Cap: -

Website

Clinical Trials

Phase I/II Clinical Trial of Proteasome Inhibitor in Combination With CPX-351 for the Treatment of Newly-Diagnosed TP53-mutated Acute Myeloid Leukemia (AML)

Phase 1

Not yet recruiting

Conditions: Acute Myeloid Leukemia
TP53

Interventions: Drug: Bortezomib
Drug: CPX-351

First Posted Date: 2025-06-06

Last Posted Date: 2025-06-06

Lead Sponsor: Masonic Cancer Center, University of Minnesota

Target Recruit Count: 32

Registration Number: NCT07008638

Allo HSCT for High Risk Hemoglobinopathies

Phase 2

Recruiting

Conditions: Graft Failure
Sickle Cell Disease
Hemoglobinopathies

Interventions: Drug: Alemtuzumab
Radiation: Total Body Irradiation
Drug: Thymoglobulin
Biological: Cell Infusion
Drug: Fludarabine
Drug: Sirolimus
Drug: Busulfan
Drug: Tacrolimus
Drug: Thiotepa
Drug: Cyclophosphamide
Drug: Mycophenolate Mofetil

First Posted Date: 2025-03-12

Last Posted Date: 2025-03-12

Lead Sponsor: Masonic Cancer Center, University of Minnesota

Target Recruit Count: 62

Registration Number: NCT06872333

Locations: 🇺🇸
Masonic Cancer Center, Minneapolis, Minnesota, United States

HM2023-43:Ph 2 Trial of Tafasitamab With Lenalidomide+Rituximab in Treatment-naive FL and MZL

Phase 2

Not yet recruiting

Conditions: Follicular Lymphoma
Marginal Zone Lymphoma

Interventions: Drug: Tafasitamab
Drug: Rituximab
Drug: Lenalidomide

First Posted Date: 2025-01-27

Last Posted Date: 2025-01-27

Lead Sponsor: Masonic Cancer Center, University of Minnesota

Target Recruit Count: 65

Registration Number: NCT06792825

Probiotic Supplementation During Cytotoxic Chemotherapy for Solid Tumor Malignancies

Not Applicable

Not yet recruiting

Conditions: Solid Tumor, Adult
Cytotoxicity

Interventions: Other: Placebo
Biological: Lactobacillus and Bifidobacterium

First Posted Date: 2025-01-13

Last Posted Date: 2025-05-30

Lead Sponsor: Masonic Cancer Center, University of Minnesota

Target Recruit Count: 40

Registration Number: NCT06772090

Adenovirus (RGDCRAdCOX2F)

Phase 1

Recruiting

Conditions: Adenocarcinoma of Pancreas

Interventions: Biological: Replicative Adenovirus Vector (RGDCRAdCOX2F)

First Posted Date: 2024-11-19

Last Posted Date: 2024-12-30

Lead Sponsor: Masonic Cancer Center, University of Minnesota

Target Recruit Count: 18

Registration Number: NCT06693986

Locations: 🇺🇸
Masonic Cancer Center, Minneapolis, Minnesota, United States

Trial of Cell Based Therapy for DMD

Phase 1

Recruiting

Conditions: Duchenne Muscular Dystrophy

Interventions: Drug: MyoPAXon
Drug: Tacrolimus

First Posted Date: 2024-11-18

Last Posted Date: 2025-03-24

Lead Sponsor: Masonic Cancer Center, University of Minnesota

Target Recruit Count: 8

Registration Number: NCT06692426

Locations: 🇺🇸
Masonic Cancer Center, Minneapolis, Minnesota, United States

HM2023-05: GTB-3650 Trike for High Risk MDS and R/R AML

Phase 1

Recruiting

Conditions: Myeloid Malignancy
Acute Myeloid Leukemia
Myelodysplastic Syndromes

Interventions: Drug: GTB-360

First Posted Date: 2024-09-19

Last Posted Date: 2025-06-29

Lead Sponsor: Masonic Cancer Center, University of Minnesota

Target Recruit Count: 45

Registration Number: NCT06594445

Locations: 🇺🇸
Masonic Cancer Center, Minneapolis, Minnesota, United States

Rural Smoking Cessation

Not Applicable

Not yet recruiting

Conditions: Smoking Cessation

Interventions: Drug: Nicoderm CQ nicotine patch
Drug: Nicorette Nicotine Lozenges

First Posted Date: 2024-09-05

Last Posted Date: 2025-06-19

Lead Sponsor: Masonic Cancer Center, University of Minnesota

Target Recruit Count: 272

Registration Number: NCT06584929

American Indian Smokefree Native RCT

Not Applicable

Recruiting

Conditions: Smoking Cessation

Interventions: Other: Smoking Cessation Program
Other: Cultural Smoking Cessation Program

First Posted Date: 2024-08-09

Last Posted Date: 2025-04-20

Lead Sponsor: Masonic Cancer Center, University of Minnesota

Target Recruit Count: 416

Registration Number: NCT06544811

Locations: 🇺🇸
Masonic Cancer Center, Minneapolis, Minnesota, United States

Remote Trial - Tobacco Product Standard (VLNC)

Not Applicable

Terminated

Conditions: Tobacco Use

Interventions: Other: Tobacco and non-tobacco e-cigarettes
Other: Tobacco only e-cigarettes

First Posted Date: 2024-06-04

Last Posted Date: 2025-04-10

Lead Sponsor: Masonic Cancer Center, University of Minnesota

Target Recruit Count: 11

Registration Number: NCT06442384

Locations: 🇺🇸
Masonic Cancer Center, Minneapolis, Minnesota, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy